STOCK BASED COMPENSATION
3 Months Ended
Mar. 31, 2013
STOCK BASED COMPENSATION [Text Block]

NOTE 13 - STOCK BASED COMPENSATION

The Company has a stock incentive plan (the “Stock Incentive Plan”) for the purpose of attracting and motivating directors, officers, employees and consultants of the Corporation and advancing the interests of the Corporation. The Stock Incentive Plan is a 15% rolling plan approved by shareholders in December 2009, whereby the Company can grant options to the extent of 15% of the current outstanding common shares. Under the plan, all forfeited and exercised options can be replaced with new offerings. As of March 31, 2013, the Company can issue stock option grants totaling up to 15,227,515 shares. Options are granted for a term of up to five years from the date of grant. Stock options granted generally vest over a period of eighteen months, with 25% vesting on the date of grant and 25% vesting every six months thereafter. Effective April 1, 2007, all grants are stated in U.S. dollars. The Company recognizes compensation expense using the straight-line method of amortization. Historically, the Company has issued new shares to satisfy exercises of stock options and the Company expects to issue new shares to satisfy any future exercises of stock options. At March 31, 2013, the Company had 10,239,625 options granted and outstanding.

On August 24, 2012, the Company granted 2,917,000 stock options to employees exercisable at a price of $0.31 until August 24, 2017.

The following table reflects the summary of stock options outstanding at March 31, 2012 and changes during for the nine months ended December 31, 2012, and the three months ended March 31, 2013:

          Weighted              
          Average     Weighted        
    Number of     Exercise     Average     Aggregate  
    shares under     Price Per     Fair     Intrinsic  
    options     Share     Value     Value  
                         
Balance outstanding, March 31, 2012   7,975,125   $ 1.38   $ 0.70   $ 5,613,510  
     Forfeited/Expired   (652,500 )   2.41     0.71     (460,975 )
     Exercised   -     -     -     -  
     Granted   2,917,000     0.31     0.16     453,774  
Balance outstanding, December 31, 2012   10,239,625     0.91     0.55     5,606,309  
     Forfeited/Expired   -     -     -     -  
     Exercised   -     -     -     -  
     Granted   -     -     -     -  
Balance outstanding, March 31, 2013   10,239,625   $ 0.91   $ 0.55   $ 5,606,309  

The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model using the assumptions noted in the following table. Expected volatilities are based on historical volatility of the Company’s stock. The Company uses historical data to estimate option volatility within the Black-Scholes model. The expected term of options granted represents the period of time that options granted are expected to be outstanding, based upon past experience and future estimates and includes data from the Plan. The risk-free rate for periods within the expected term of the option is based upon the U.S. Treasury yield curve in effect at the time of grant. The Company currently does not foresee the payment of dividends in the near term.

The fair value of the stock options granted was estimated using the Black-Scholes option-pricing model and is amortized over the vesting period of the underlying options. The assumptions used to calculate the fair value are as follows:

    Three Months     Nine Months  
    Ended March 31,     Ended December  
    2013     31, 2012  
Dividend yield   0     0  
Expected volatility   65 - 70%     65 - 70%  
Risk free interest rate   0.19 - 0.33%     0.19 - 0.33%  
Expected life (years)   3.17     3.17  

Changes in the subjective input assumptions can materially affect the fair value estimate and, therefore, the existing models do not necessarily provide a reliable measure of the fair value of the Company’s stock options.

The following table summarizes information about the stock options outstanding at March 31, 2013:

OPTIONS OUTSTANDING              
          REMAINING     NUMBER OF        
EXERCISE   NUMBER OF     CONTRACTUAL     OPTIONS        
PRICE   OPTIONS     LIFE (YEARS)     EXERCISABLE     INTRINSIC VALUE  
                         
$2.22   1,465,000     0.13     1,465,000   $ 1,786,417  
1.78   95,000     0.49     95,000     81,172  
  0.92   1,704,625     1.15     1,704,625     1,204,713  
  1.58   68,000     1.48     68,000     26,435  
  0.86   1,300,000     2.45     1,300,000     752,207  
0.83   2,590,000     3.18     2,590,000     1,269,100  
0.60   100,000     3.45     100,000     36,072  
  0.31   2,917,000     4.40     1,458,500     226,888  
$0.91   10,239,625     2.63     8,781,125   $ 5,383,004  

The following table summarizes information about the stock options outstanding at December 31, 2012:

OPTIONS OUTSTANDING              
          REMAINING     NUMBER OF        
EXERCISE   NUMBER OF     CONTRACTUAL     OPTIONS        
PRICE   OPTIONS     LIFE (YEARS)     EXERCISABLE     INTRINSIC VALUE  
                         
$2.22   1,465,000     0.63     1,465,000   $ 1,786,417  
  1.78   95,000     0.74     95,000     81,172  
  0.92   1,704,625     1.40     1,704,625     1,204,713  
  1.58   68,000     1.73     68,000     26,435  
  0.86   1,300,000     2.70     1,300,000     752,207  
  0.83   2,590,000     3.43     2,590,000     1,269,100  
  0.60   100,000     3.70     75,000     27,054  
  0.31   2,917,000     4.65     729,250     113,444  
$0.91   10,239,625     2.80     8,026,875   $ 5,260,542  

A summary of the status of the Company’s nonvested stock options outstanding at March 31, 2012 and changes during the nine months ended December 31, 2012, and the three months ended March 31, 2013 are presented as follows:

          Weighted     Weighted  
          Average Grant     Average  
    Number of     Date Fair Value     Grant Date  
    Options     Per Share     Fair Value  
                   
Nonvested, March 31, 2012   1,345,000   $ 0.82   $ 0.49  
     Granted   2,917,000     0.31     0.16  
     Vested   (2,049,250 )   0.64     0.37  
     Forfeited/Expired   -     -     -  
Nonvested, December 31, 2012   2,212,750     0.31     0.16  
     Granted   -     -     -  
     Vested   (754,250 )   0.32     0.16  
     Forfeited/Expired   -     -     -  
Nonvested, March 31, 2013   1,458,500   $ 0.31   $ 0.16  

As of March 31, 2013, there was $56,356 of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.5 years. The total fair value of options vested at March 31, 2013 and 2012 was $59,362 and $225,276 ; respectively.

Stock Compensation Plan (Restricted Shares )

On September 10, 2010, the Company granted officers, directors and select employees 705,000 common shares that will be distributed in three six-month vesting periods. The recipients meet the vesting requirements by maintaining employment and good standing with the Company through the vesting periods. After vesting, there are no restrictions on the shares. On March 10, 2011, the 705,000 common shares were issued to the recipients and held by the Company. All of these shares were considered to be issued and outstanding. On March 11, 2011, 235,000 common shares vested valued at $0.99 per share, and the shares were released to the qualified recipients. On September 11, 2011, 235,000 common shares vested valued at $0.60 per share and the shares were released to the qualified recipients. The final 235,000 shares valued at $0.58 vested and were released on March 11, 2012.

Stock Purchase Warrants

At March 31, 2013, the outstanding broker warrants and share purchase warrants consisted of the following:

          Broker              
          Warrant     Share     Warrant  
    Broker     Exercise     Purchase     Exercise  
             Expiration Date   Warrants     Price     Warrants     Price  
                         
September 16, 2015   246,285   $ 1.250     4,104,757   $ 1.250  
May 31, 2017   255,721     0.437     -     -  
December 21, 2017   -     -     5,905,408     0.50  

On March 4, 2012, 2,500,000 stock purchase warrants and 56,000 broker warrants at an exercise price of $1.075 expired without exercise.